General Information
Drug ID
DR00300
Drug Name
Fostamatinib
Synonyms
901119-35-5; Fostamatinib [USAN:INN]; R 788; R-788; R-788 Free acid; R-935788 Free acid; R788; R7935788; SQ8A3S5101; Tavalisse; UNII-SQ8A3S5101
Drug Type
Small molecular drug
Indication Rheumatoid arthritis [ICD11: FA20] Approved [1]
Structure
3D MOL 2D MOL
Formula
C23H26FN6O9P
Canonical SMILES
CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C
InChI
InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29)
InChIKey
GKDRMWXFWHEQQT-UHFFFAOYSA-N
CAS Number
CAS 901119-35-5
Pharmaceutical Properties Molecular Weight 580.5 Topological Polar Surface Area 187
Heavy Atom Count 40 Rotatable Bond Count 10
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 15
XLogP
1.6
PubChem CID
11671467
PubChem SID
124360793 , 125164706 , 125299332 , 126665637 , 134338877 , 135262180 , 135693729 , 136367938 , 137245316 , 141853032 , 144115995 , 152159558 , 152344305 , 160681714 , 162038039 , 164043535 , 164160256 , 16775273 , 170501470 , 172087031 , 172818901 , 174006453 , 174531355 , 185997057 , 188941735 , 198973453 , 206261469 , 210274820 , 210280453 , 223366127 , 223388366 , 223684830 , 227435155 , 23769915 , 242060176 , 246229128 , 251971029 , 252215442 , 75389485 , 96026027
TTD Drug ID
D0V8HJ
DT(s) Transporting This Drug ABCB5 Transporter Info ATP-binding cassette sub-family B member 5 Substrate [2]
References
1 Fostamatinib was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. (ID: DB12010)

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.